Paula Traquina

Title: Paula Traquina: Innovator in Immunogenic Composition Against SARS-CoV-2

Introduction

Paula Traquina is a prominent inventor based in Emeryville, CA (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines against viral infections. Her work is especially relevant in the context of the ongoing global health challenges posed by coronaviruses.

Latest Patents

Paula Traquina holds a patent for an immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This invention focuses on an immunogenic composition that includes a recombinant SARS-CoV-2 S protein and an adjuvant. This innovative approach aims to enhance the immune response against the virus, contributing to the fight against COVID-19.

Career Highlights

Throughout her career, Paula has worked with notable organizations in the biotechnology sector. She has been associated with Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation, where she has played a crucial role in vaccine development and research.

Collaborations

Paula has collaborated with esteemed colleagues, including Tsun-Yung Kuo and Charles Chen. These partnerships have furthered her research and contributed to advancements in immunogenic compositions.

Conclusion

Paula Traquina's work in developing an immunogenic composition against SARS-CoV-2 highlights her innovative spirit and dedication to public health. Her contributions are vital in the ongoing efforts to combat viral diseases and improve vaccine efficacy.